20 February 2013
Subcutaneous application of levothyroxine as successful treatment option in a patient with malabsorption
Jan B. GroenerABDEF, Daniel LehnhoffDE, David PielDEF, Peter P. NawrothE, Jurik SchanzABDE, Gottfried RudofskyABDEDOI: 10.12659/AJCR.883788
Am J Case Rep 2013; 14:48-51
Abstract
Background: Hypothyroidism can usually be treated effectively by oral levothyroxine supplementation. There are, however, some rare circumstances, when oral levothyroxine application is not sufficient, for example malabsorption, interactions with food or other medications, or various gastrointestinal diseases.
Case Report: We present a 42 year old woman with refractory and severe symptomatic hypothyroidism after subtotal thyroidectomy in spite of high dose oral levothyroxine supplementation. By stepwise increasing oral levothyroxine dosage up to 2200 micrograms plus 80 micrograms of thyronine, no sufficient substitution could be achieved. After suspicion of enteral malabsorption due to a pathological D-Xylose-test, subcutaneous levothyroxine supplementation was started. Finally, a sustained euthyroid state could be achieved.
Conclusions: For selected patients who do not respond to oral treatment subcutaneous application of levothyroxine can be a suitable and effective therapy.
Keywords: Hypothyroidism, levotriiodothyronine, L-thyroxine, total thyroidectomy, Injections, Subcutaneous
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945921
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946916
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946269
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948017
Most Viewed Current Articles
21 Jun 2024 : Case report
93,397
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,131
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
27,838
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,970
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030